πŸ‡ΊπŸ‡Έ FDA
Patent

US 10844058

Valbenazine salts and polymorphs thereof

granted A61PA61P25/00A61P25/14

Quick answer

US patent 10844058 (Valbenazine salts and polymorphs thereof) held by Neurocrine Biosciences, Inc. expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P25/00, A61P25/14